Oxymetazoline
Oxymetazoline is a decongestant and alpha-adrenergic agonist used across several products to relieve nasal congestion, reduce facial redness from rosacea, and treat drooping of the upper eyelid.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 197 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Oxymetazoline: Patient Information Guide
A plain-language walkthrough of Oxymetazoline — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Oxymetazoline is available in several different forms, each approved for a distinct use.
- Nasal congestion relief: Nasal sprays — including Afrin, Dristan, CVS Severe Nasal Congestion Relief, Best Choice, Assured Nasal Relief Original, and Family Care Nasal Relief — temporarily relieve nasal congestion due to colds, hay fever, and other upper respiratory allergies. They also help relieve sinus congestion and pressure by shrinking swollen nasal membranes.
- Facial redness from rosacea: Rhofade (topical cream) and Oxymetazoline Hydrochloride cream are approved to treat persistent facial erythema (redness) associated with rosacea in adults.
- Drooping upper eyelid: Upneeq (ophthalmic solution/eye drops) is approved to treat acquired blepharoptosis — a drooping of the upper eyelid — in adults.
⚙️How it works▾
Oxymetazoline activates alpha-adrenergic receptors — proteins on the surface of blood vessel walls and muscle cells that signal them to contract. When blood vessels constrict (tighten), swelling and redness go down. In the nasal passages, this shrinks swollen tissue so air moves through more freely. Applied to the skin, the cream targets alpha-1A adrenoceptors to reduce the visible redness of rosacea. In Upneeq eye drops, oxymetazoline acts specifically on receptors in Mueller's muscle, a small muscle in the upper eyelid, causing it to contract and lift a drooping lid.
💊How it's taken▾
How you use oxymetazoline depends on the form prescribed or recommended.
- Nasal sprays: 2 or 3 sprays per nostril for adults and children 6 and older, no more than every 10–12 hours, with a maximum of 2 doses in 24 hours. Do not use for more than 3 days in a row.
- Facial cream (Rhofade and Oxymetazoline Hydrochloride): Apply a pea-sized amount once daily in a thin layer across the full face, avoiding eyes and lips. Wash hands right after.
- Upneeq eye drops: One drop into the affected eye(s) once daily. Remove contact lenses first; wait 15 minutes before reinserting. If using other eye drops, wait at least 15 minutes between products.
Always follow the directions on your product label or from your prescriber — do not adjust timing or amount on your own.
🤒Side effects — in detail▾
Side effects vary by form. Here are the most common ones reported on the label:
- Application site skin irritation or dermatitis (facial cream)
- Worsening of inflammatory rosacea lesions (facial cream)
- Itching, redness, or pain at the application site (facial cream)
- Temporary burning, stinging, or sneezing (nasal spray)
- Temporary increase in nasal discharge (nasal spray)
Stop nasal spray use and see a doctor if symptoms persist beyond 3 days. For eye drops, seek immediate care if you experience eye pain, redness, blurred vision, or light sensitivity — these may signal a serious eye condition.
⚠️Warnings & precautions▾
- Drooping eyelid may signal a serious condition: Upneeq is used for eyelid drooping, but that drooping can sometimes be caused by neurological diseases like stroke, cerebral aneurysm, myasthenia gravis, or Horner syndrome. If drooping comes with other neurological symptoms, see a doctor before using eye drops.
- Blood pressure effects: Because oxymetazoline affects blood vessels, it can influence blood pressure. People with cardiovascular disease, uncontrolled high or low blood pressure, or dizziness when standing (orthostatic hypotension) should use any form with caution and contact a doctor immediately if their condition worsens.
- Nasal spray overuse: Using nasal spray for more than 3 days can cause rebound congestion — meaning your stuffy nose comes back worse. Stick to the 3-day limit.
- Angle closure glaucoma risk: Upneeq may increase the risk of acute angle closure glaucoma in people with untreated narrow-angle glaucoma. Seek emergency care if you develop eye pain, redness, blurred vision, or sensitivity to light.
- Children and accidental ingestion: Keep all oxymetazoline products out of children's reach. If a child swallows any form, call Poison Control immediately at 1-800-222-1222.
🔀What it interacts with▾
Oxymetazoline can interact with several types of medications because of its effects on blood vessels and the nervous system.
- Beta-blockers and antihypertensives (blood pressure medications): Oxymetazoline may affect blood pressure, making these combinations potentially unpredictable.
- Cardiac glycosides (heart rhythm medications): Use with caution alongside oxymetazoline.
- Alpha-adrenergic receptor blockers (used for heart disease or benign prostatic hypertrophy — an enlarged prostate): May interact with oxymetazoline's mechanism of action.
- MAO inhibitors (certain antidepressants): These can affect how the body processes oxymetazoline; use with caution and inform your prescriber.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor if you have heart disease, high blood pressure, thyroid disease, or diabetes before using nasal sprays.
- Tell your doctor if you have difficulty urinating due to an enlarged prostate before using nasal sprays.
- Upneeq should be used with caution if you have severe or unstable cardiovascular disease, uncontrolled high or low blood pressure, or cerebral or coronary insufficiency (reduced blood flow to the brain or heart).
- Tell your eye doctor if you have glaucoma — Upneeq may increase the risk of angle closure glaucoma in people with untreated narrow-angle glaucoma.
- Tell your doctor if you have Sjögren's syndrome, as Upneeq should be used with caution.
- Pregnancy: A possible link between second-trimester nasal oxymetazoline use and kidney development abnormalities in the baby has been identified in one study. Discuss the risks with your doctor before using any form during pregnancy.
- Breastfeeding: It is not known how much oxymetazoline passes into breast milk. Talk to your healthcare provider before using.
- Children: The facial cream has not been studied in children under 18. Nasal sprays should not be used in children under 6 without a doctor's guidance, and not at all in children under 2.
- Older adults: Clinical trials of the facial cream did not find major safety differences in adults 65 and older compared to younger adults, but individual monitoring remains appropriate.
🚑If you take too much▾
The facial cream and eye drops are not for swallowing — if ingested accidentally, seek medical advice immediately. Accidental swallowing of oxymetazoline nasal spray — especially by children — has caused serious problems including nausea, vomiting, drowsiness, irregular heart rate, low blood pressure, and even coma. If this happens, call Poison Control right away at 1-800-222-1222 or go to the emergency room.
📡Pharmacodynamics — effects in the body▾
In clinical studies of Upneeq, the effect on eyelid lift was measured using a standard distance called MRD1 (marginal reflex distance 1) — the gap between the pupil's light reflection and the edge of the upper eyelid. The greatest eyelid lift was seen about 2 hours after a dose, and the effect continued through 8 hours after dosing. This shows Upneeq provides meaningful eyelid elevation for the better part of a day with once-daily use.
🔬Pharmacokinetics — how your body processes it▾
When oxymetazoline cream is applied to the face, small amounts are absorbed into the bloodstream, but levels remain very low. The drug is about 57% bound to plasma proteins in the blood. It is minimally broken down (metabolized) by the liver — studies show that nearly 96% of the drug remains unchanged after 2 hours of processing by liver enzymes. In lab studies, oxymetazoline did not significantly interfere with the liver enzyme system (cytochrome P450) that processes many other medications. How the body eliminates oxymetazoline after skin application has not been fully studied in humans.
📦How to store it▾
store between 20° and 25°C (68° to 77°F) retain carton for future reference on full labeling
📄 Written from Oxymetazoline’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Oxymetazoline — the kind of thing our pharmacy team would talk through with you at the counter.
Can I use the nasal spray for more than a few days if my congestion keeps coming back? ▾
What exactly does Upneeq do for a drooping eyelid — will it fix the problem permanently? ▾
I use blood pressure medication. Is it safe to use oxymetazoline? ▾
Can I use the facial cream if I'm pregnant or breastfeeding? ▾
My child accidentally got into the nasal spray. What should I do? ▾
How do I apply Rhofade cream correctly so it works and doesn't irritate my skin? ▾
Is Oxymetazoline available over the counter? ▾
When was Oxymetazoline first available? ▾
Who makes Oxymetazoline? ▾
💬 Answers drafted from Oxymetazoline’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Oxymetazoline comes
Oxymetazoline is available in 6 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Nasal spray
How this form is used
- Temporarily relieves nasal congestion due to colds, hay fever, or other upper respiratory allergies
- Helps relieve sinus congestion and pressure
- Shrinks swollen nasal membranes to help restore easier breathing
- For adults and children 6 and older: 2 or 3 sprays in each nostril, no more than every 10–12 hours; do not exceed 2 doses in 24 hours
- Do not use for more than 3 days — prolonged use can cause congestion to come back or worsen
- Shake well before use; without tilting your head, insert nozzle into nostril and spray with a firm, even stroke while sniffing deeply
- Wipe the nozzle clean after each use and do not share the container with others
Show 9 more strengths Show fewer strengths
Topical cream, ointment or gel
How this form is used
- Rhofade is used to treat persistent facial redness (erythema) associated with rosacea in adults
- Oxymetazoline Hydrochloride cream is used to treat persistent facial redness associated with rosacea in adults
- Rhofade: prime the pump before the first use by pressing until cream is dispensed, then pump 3 more times and discard that cream; tube forms do not require priming
- Rhofade and Oxymetazoline Hydrochloride cream: apply a pea-sized amount once daily in a thin layer across the entire face — forehead, nose, cheeks, and chin — avoiding eyes and lips
- Wash hands immediately after applying
- For topical use only — not for use in the eyes, by mouth, or vaginally
Topical solution
Eye drops
How this form is used
- Upneeq is used to treat acquired blepharoptosis (drooping of the upper eyelid) in adults
- Upneeq: instill one drop into the affected eye(s) once daily
- Upneeq: remove contact lenses before applying; wait 15 minutes before reinserting them
- Upneeq: if using other eye drops, wait at least 15 minutes between each product
- Upneeq: do not touch the dropper tip to your eye or any surface — discard the single-use container right after use
Topical spray
Nasal topical
📊 Oxymetazoline across the U.S. market
How Oxymetazoline appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (9) · Kit (1) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Oxymetazoline is used
A general measure of how commonly Oxymetazoline is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Oxymetazoline is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Oxymetazoline prescribed? Of the 1,594 medications we measure, Oxymetazoline ranks #796 by Medicaid prescriptions — more than 50% of them.
Utilization by Oxymetazoline product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray Most dispensed
Summed across the 11 of 351 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1000990
oxymetazoline hydrochloride 10 MG/ML Topical Cream
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1869816
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Oxymetazoline, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 13 of 356 listed Oxymetazoline NDCs with Medicaid activity.
🔍 Compare Oxymetazoline products
A representative set of FDA-listed product records for Oxymetazoline — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 1 mg/mL | Ophthalmic | RVL Pharmaceuticals, Inc. × 4 listings | NDA | View NDC → |
| 💊Nasal spray | ||||
| 0.5 mg/mL | Nasal | A-S Medication Solutions × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | A-S Medication Solutions × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | A-S Medication Solutions × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Accent Pharma × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Alaina Healthcare Private Limited × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Amazon.com Services LLC × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Amazon.com Services LLC × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | American Sales Company × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | American Sales Company × 4 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Amerisource Bergen × 5 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Amerisource Bergen × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Army & Air Force Exchange Service | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Army & Air Force Exchange Service × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Nasal | Bayer HealthCare LLC. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Nasal | Bayer HealthCare LLC. | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Bayer HealthCare LLC. × 5 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Bayer HealthCare LLC. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 g/100 mL | Nasal | Bayer HealthCare LLC. × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 g/100 mL | Nasal | Bayer HealthCare LLC. | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Best Choice (valu Merchandisers Company) × 10 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Best Choice (valu Merchandisers Company) × 11 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Bi-Mart × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Big Lots Stores, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Bjwc | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Nasal | Cardinal Health 110,Inc × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Cardinal Health 110, LLC. dba Leader | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Chain Drug Marketing Association × 7 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Chain Drug Marketing Association × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 mg/mL | Nasal | Chain Drug Marketing Association Inc | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 mg/mL | Nasal | Chain Drug Marketing Association Inc | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Chain Drug Marketing Association Inc. × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Chain Drug Marketing Association Inc. × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Nasal | Church & Dwight Co., Inc. × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Nasal | Church & Dwight Co., Inc. × 4 listings | OTC MONOGRAPH FINAL | View NDC → |
| 50 mg/100 mL | Nasal | CVS Health × 4 listings | OTC MONOGRAPH DRUG | View NDC → |
| 50 mg/100 mL | Nasal | CVS Health × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | CVS Pharmacy | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | CVS Pharmacy × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Cvs Pharmacy, Inc | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Cvs Pharmacy, Inc | OTC MONOGRAPH FINAL | View NDC → |
| 0.0005 g/mL | Nasal | CVS Pharmacy,Inc. | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Cvs Pharmacy, Inc. × 6 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Cvs Pharmacy, Inc. × 6 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Discount Drug Mart × 5 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Discount Drug Mart × 10 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Dolgencorp, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Dolgencorp, Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Dolgencorp, LLC × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Nasal | Dolgencorp, LLC × 5 listings | OTC MONOGRAPH FINAL | View NDC → |
| 50 mg/100 mL | Nasal | FAMILY DOLLAR (Family Wellness) × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 50 mg/100 mL | Nasal | FAMILY DOLLAR (Family Wellness) | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | RB Health (US) LLC × 3 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Reckitt Benckiser LLC × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 50 mg/100 mL | Nasal | Sheffield Pharmaceuticals LLC | OTC MONOGRAPH FINAL | View NDC → |
| 50 mg/100 mL | Nasal | Sheffield Pharmaceuticals LLC | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Nasal | Vivunt Pharma Llc × 3 listings | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/15 mL | Nasal | Walgreens | OTC MONOGRAPH FINAL | View NDC → |
| 0.05 g/100 mL | Nasal | Walgreens | OTC MONOGRAPH FINAL | View NDC → |
| 50 mg/100 mL | Nasal | Walgreens | OTC MONOGRAPH FINAL | View NDC → |
| 50 mg/100 mL | Nasal | Walgreens Company × 2 listings | OTC MONOGRAPH DRUG | View NDC → |
| 50 mg/100 mL | Nasal | Walgreens Company | OTC MONOGRAPH FINAL | View NDC → |
| 50 mg/mL | Nasal | Walgreens Company | OTC MONOGRAPH DRUG | View NDC → |
| 💊Nasal topical | ||||
| 0.05 {VP}/100{VP} | Nasal | Profounda Inc | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 {VP}/100{VP} | Nasal | Profounda Inc | OTC MONOGRAPH FINAL | View NDC → |
| 💊Topical cream, ointment or gel | ||||
| 10 mg/g | Topical | Allergan, Inc. | NDA | View NDC → |
| 1 g/100 g | Topical | EPI Health, LLC × 2 listings | NDA | View NDC → |
| 10 mg/g | Topical | Mayne Pharma × 2 listings | NDA | View NDC → |
| 10 mg/g | Topical | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 10 mg/g | Topical | Taro Pharmaceuticals U.S.A., Inc. | ANDA | View NDC → |
| 💊Topical solution | ||||
| 0.05 g/100 mL | Topical | Dr. Friedman's No More Nosebleed Kit Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 0.05 g/100 mL | Topical | Dr. Friedman's No More Nosebleed Kit Inc. × 2 listings | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Topical | Genomma Lab USA | OTC MONOGRAPH DRUG | View NDC → |
| 0.5 mg/mL | Topical | Genomma Lab USA | OTC MONOGRAPH FINAL | View NDC → |
| 0.5 mg/mL | Topical | Medic -33, Inc. | OTC MONOGRAPH DRUG | View NDC → |
| 💊Kits | ||||
| — | Nasal | Bayer HealthCare LLC. | OTC MONOGRAPH DRUG | View NDC → |
| 💊Bulk drug substance | ||||
| 1 g/g | — | AX Pharmaceutical Corp. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 25 kg/25 kg | — | CTX Lifesciences Pvt. Ltd. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Darmerica, Llc | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Shodhana Laboratories Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Siegfried PharmaChemikalien Minden GmbH | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Suresource Pharma LLC | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
Showing 200 of 485 products — FDA National Drug Code Directory. See every product, package size and price: browse all 485 Oxymetazoline NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Oxymetazoline — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Oxymetazoline in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Oxymetazoline went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 7812 5 dose forms · 10 strengths
-
Dose form (SCDF) Nasal Gel RxCUI 2474263In current FDA listingsClinical drug / strength (SCD) hydrochloride 0.0005 MG/MGRxCUI 2474264 -
Dose form (SCDF) Nasal Solution RxCUI 377397In current FDA listingsClinical drug / strength (SCD) hydrochloride 0.25 MG/MLRxCUI 1000978hydrochloride 0.5 MG/MLRxCUI 1000987 -
Dose form (SCDF) Nasal Spray RxCUI 374488In current FDA listingsClinical drug / strength (SCD) hydrochloride 0.25 MG/MLRxCUI 2606550hydrochloride 0.5 MG/MLRxCUI 1000990hydrochloride 2.5 MG/MLRxCUI 1037203 -
Dose form (SCDF) Ophthalmic Solution RxCUI 377448In current FDA listingsClinical drug / strength (SCD) hydrochloride 0.25 MG/MLRxCUI 1000981hydrochloride 0.5 MG/MLRxCUI 1001378hydrochloride 1 MG/MLRxCUI 2391749 -
Dose form (SCDF) Topical Cream RxCUI 1869815In current FDA listingsClinical drug / strength (SCD) hydrochloride 10 MG/MLRxCUI 1869816
Look up RxCUI 7812 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Oxymetazoline is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Oxymetazoline belongs to the Vasoconstrictor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 197 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. FAMILY DOLLAR (Family Wellness) is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.